| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.006 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.095 | 0.006 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.007 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.007 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.16 | 0.008 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.008 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |